Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.15 | 50.18 |
| PEG Ratio (TTM) | -0.01 | 0.26 |
| P/S Ratio (TTM) | N/A | 3.71 |
| P/B Ratio (TTM) | 0.01 | 2.57 |
| P/FCF Ratio (TTM) | N/A | 36.02 |
| Price to 5YR AVG Earnings Ratio | N/A | 52.54 |
| Price to 5YR AVG FCF Ratio | N/A | 30.46 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.77% | 1.30% |
| ROE (TTM) | 5.02% | -2.51% |
| Net Profit Margin (TTM) | 39,525.09% | -1.48% |
| ROIC 5YR AVG | N/A | 140.80% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.68% | N/A | N/A |
| Revenue | -0.06% | N/A | N/A |
| Net Income | 35.53% | N/A | N/A |
| Cash Flow | -30.94% | N/A | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.16 | 3.03 |
| Quick Ratio (TTM) | 3.60 | 3.00 |
| D/E Ratio (TTM) | 0.00 | 1.39 |
| Interest Coverage (TTM) | -574.59 | -0.61 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | N/A | 4.22 |
| LTL to 5YR AVG FCF | N/A | 51.74 |
| Shares Outstanding Growth 5YR AVG | N/A | 65.07% |